North Carolina urologist Dr. Hector Henry dies at 75
Hector H. Henry, II, MD, MPH, of Concord, NC, who practiced adult and pediatric urology for over 40 years, has died. He was 75.
Hector H. Henry, II, MD, MPH, of Concord, NC, who practiced adult and pediatric urology for over 40 years, has died. He was 75.
Dr. HenryA urology professor at Duke University for 33 years and at Wake Forest University for 7 years, Dr. Henry was the longest-serving member of the North Carolina Medical Board. He held a number of administrative roles at health care institutions, including vice president of Medical Affairs at CMC-NorthEast Medical Center in Concord.
Dr. Henry received recognition for projects in prostate health and, as state surgeon, for innovations in health care delivery in rural and impoverished North Carolina communities, according to his obituary.
A retired colonel in the United States Army Reserves Medical Corps, Dr. Henry served the country for over 40 years as an officer, medical provider, and commander. He received a Joint Commendation and three Bronze Stars, among others medals, for achievements in combat.
Dr. Henry obtained his doctor of medicine with honors from Tulane University and his Bachelor of Science in chemistry and Master of Public Health from the University of North Carolina, Chapel Hill. He completed his surgical and urological residencies at Ochsner Foundation Hospital and Clinic and fellowship in pediatric urology at the Pediatric Urological Institute and Great Ormond Street Hospital in London.
Dr. Henry is survived by his wife Marjorie Benbow, three sons, and three grandchildren. He was preceded in death by his sister Janie.
A past president and historian of the AUA Southeastern Section and an avid runner, Dr. Henry will be honored with the naming of the “The First Annual Hector Henry Memorial Run/Walk,” which will be held at the section’s annual meeting in Hollywood, FL on March 22. Sponsorship opportunities are available, with tax-deductible proceeds going to the Hollywood chapter of the Leukemia and Lymphoma Society.
Contact Jon Demos, MD, Southeastern Section treasurer (jdemos@twc.com), for details on sponsorship.
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
